Akinsanya Karen — SEC insider filings
SEC reporting owner CIK 1797672. 22 insider filings on record with FilingPulse; latest filed 2026-09-21.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2020-08-14 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 29 legs across 11 filings — 145,926 shares, $7,642,425 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 46.
- Largest priced transaction: sale of 21,691 shares @ $57.43 ($1,245,788) in Schrodinger, Inc., filed 2021-08-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Schrodinger, Inc. (SDGR) | See Remarks | 16 | — | 29 legs · 145,926 sh · $7,642,425 | 40 |
| Nautilus Biotechnology, Inc. (NAUT) | Director | 6 | — | — | 6 |
Insider filings — Akinsanya Karen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 31,599 @ $4.34 · Sale (S): 10,000 @ $28 · Sale (S): 21,599 @ $30 · Option exercise (M): 31,599 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Nautilus Biotechnology, Inc. (NAUT) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Schrodinger, Inc. (SDGR) | Sale (S): 1,366 @ $12.90 | EDGAR |
| 2026-03-03 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 24,250 @ $0 · Grant/award (A): 6,077 @ $0 · Grant/award (A): 27,576 @ $0 · Sale (S): 2,206 @ $11.99 · Grant/award (A): 48,500 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Nautilus Biotechnology, Inc. (NAUT) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-04-15 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 13,378 @ $3.22 · Option exercise (M): 3,345 @ $2.92 · Sale (S): 8,378 @ $25.11 · Sale (S): 5,000 @ $25.11 · Sale (S): 3,345 @ $25 · Option exercise (M): 13,378 (derivative) @ $0 · +1 more | EDGAR |
| 2025-03-04 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 15,625 @ $0 · Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Nautilus Biotechnology, Inc. (NAUT) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Nautilus Biotechnology, Inc. (NAUT) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2023-02-10 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 63,270 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Nautilus Biotechnology, Inc. (NAUT) | Grant/award (A): 14,411 (derivative) @ $0 | EDGAR |
| 2022-03-31 | 4 | Nautilus Biotechnology, Inc. (NAUT) | Grant/award (A): 105,998 (derivative) @ $0 | EDGAR |
| 2022-02-09 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2021-10-19 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 1,393 @ $4.34 · Sale (S): 1,393 @ $55.75 · Option exercise (M): 1,393 (derivative) @ $0 | EDGAR |
| 2021-09-16 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 1,394 @ $4.34 · Sale (S): 1,394 @ $61.13 · Option exercise (M): 1,394 (derivative) @ $0 | EDGAR |
| 2021-08-17 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 20,181 @ $17 · Option exercise (M): 4,180 @ $4.34 · Option exercise (M): 13,377 @ $3.22 · Sale (S): 21,691 @ $57.43 · Sale (S): 16,047 @ $58.17 · Option exercise (M): 20,181 (derivative) @ $0 · +2 more | EDGAR |
| 2021-06-09 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 6,479 @ $4.34 · Sale (S): 6,479 @ $75.10 · Option exercise (M): 10,242 @ $4.34 · Sale (S): 9,442 @ $75.49 · Sale (S): 800 @ $76.08 · Option exercise (M): 6,479 (derivative) @ $0 · +1 more | EDGAR |
| 2021-03-02 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2020-12-22 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 13,377 @ $3.22 · Sale (S): 13,377 @ $80 · Option exercise (M): 13,377 (derivative) @ $0 | EDGAR |
| 2020-08-19 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 3,344 @ $2.92 · Sale (S): 2,910 @ $67.88 · Sale (S): 334 @ $68.81 · Sale (S): 100 @ $70.04 · Option exercise (M): 3,344 (derivative) @ $0 | EDGAR |
| 2020-08-14 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 13,377 @ $3.22 · Option exercise (M): 3,344 @ $2.92 · Option exercise (M): 3,344 @ $2.92 · Sale (S): 200 @ $65.08 · Sale (S): 2,697 @ $66.53 · Sale (S): 7,839 @ $67.35 · +11 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1797672 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs